| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: group of inventions relates to peptides, isolated from human basic proline-rich lacrimal protein (BPLP), in particular to opiorphin, and is intended for application in manufacturing medication for treatment or prevention of such disease as obsessive-compulsive disorder, narcolepsy, hypersomnia, reduction of vigilance, deficit of attention in children, bipolar disease, dysthymic disorder and cyclothymic disorder.EFFECT: application of group of inventions ensures application of peptides, which do not have at all or have very weak side effects.15 cl, 3 dwg, 6 tbl, 7 ex |
